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Introduction: Mesenteric ischemia-reperfusion injury (IRI) leads to systemic inflammation and multiple organ failure in
clinical and laboratory settings. We investigated the lung structural, functional, and genomic response to mesenteric IRI
with and without regional intraischemic hypothermia (RIH) in rodents and hypothesized that RIH would protect the
lung and preferentially modulate the distant organ transcriptome under these conditions.
Methods: Sprague-Dawley rats underwent sham laparotomy or superior mesenteric artery occlusion (SMAO) for 60
minutes with or without RIH. Gut temperature was maintained at 15°-20°C during SMAO, and systemic normothermia
(37°C) was maintained throughout the study period. At 6 or 24 hours, lung tissue was collected for (1) histology, (2)
myeloperoxidase activity, (3) bronchoalveolar lavage (BAL) fluid protein concentrations, (4) lung wet/dry ratios, and (5)
total RNA isolation and hybridization to Illumina’s Sentrix BeadChips (>22,000 probes) for gene expression profiling.
Significantly affected genes (false discovery rate <5% and fold change >1.5) were linked to gene ontology (GO) terms
using MAPPFinder, and hypothermia-suppressed genes were further analyzed with Pubmatrix.
Results: Mesenteric IRI-induced lung injury, as evidenced by leukocyte trafficking, alveolar hemorrhage, and increased
BAL protein and wet/dry ratios, and activated a proinflammatory lung transcriptome compared with sham. In contrast,
rats treated with RIH exhibited lung histology, BAL protein, and wet/dry ratios similar to sham. At 6 hours, GO analysis
identified 232 hypothermia-suppressed genes related to inflammation, innate immune response, and cell adhesion, and 33
hypothermia-activated genes related to lipid and amine metabolism and defense response. Quantitative real-time
polymerase chain reaction validated select array changes in top hypothermia-suppressed genes lipocalin-2 (lcn-2) and
chemokine ligand 1 (CXCL-1), prominent genes associated with neutrophil activation and trafficking.
Conclusions: Therapeutic hypothermia during SMAO provides distant organ protection and preferentially modulates the
IRI-activated transcriptome in the rat lung. This study identifies potential novel diagnostic and therapeutic targets of
mesenteric IRI and provides a platform for further mechanistic study of hypothermic protection at the cellular and
subcellular level. ( J Vasc Surg 2010;52:1003-14.)
Clinical Relevance:Visceral organ ischemia-reperfusion injury (IRI) is a common clinical problem in the settings of shock,
sepsis, vascular surgery, and organ transplantation and is a particularly vexing problem in the repair of complex aortic
aneurysms. IRI is associated with considerable patient morbidity and mortality, for which there are virtually no
therapeutic options. It systematically causes local organ injury and dysfunction, systemic inflammation, and multiple
organ failure. Clinical trials investigating the efficacy of pharmacologic blockade of individual downstream inflammatory
mediators in critically ill patients have been largely unsuccessful, and such studies highlight the need for novel top-down
approaches, such as gene expression profiling for biologic discovery, as well as application of broader therapeutic
interventions, such as targeted hypothermia. In this study, we demonstrate the potential application of visceral cooling
for distant organ protection during mesenteric IRI, identify broad changes in lung gene expression under these
conditions, and have elucidated potential novel diagnostic and therapeutic targets for disease targeting.From the Department of Surgery, The Methodist Hospital and Research
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doi:10.1016/j.jvs.2010.05.088Mesenteric ischemia-reperfusion injury (IRI) occurs in
various clinical settings including shock, sepsis, and complex
aortic surgery. It incites an inflammatory response associated
with local gut dysfunction as well as neutrophil (polymorpho-
nuclear [PMN]) activation and remote organ injury.1-5 Nu-
merous effectors have been implicated in this injury cascade,
including cytokines, lipid mediators, nitric oxide, and cell
adhesion molecules.6-10 Unfortunately, clinical trials investi-
gating the efficacy of pharmacologic blockade of these various
downstream inflammatory mediators in critically ill patients
have been largely unsuccessful.11,12 It has become clear that a
more thorough top-down approach to biologic discovery and
implementation of interventions with broader therapeutic ap-
plication are needed to improve outcomes in these clinical
settings.
Therapeutic hypothermia is cytoprotective in various
IRI models, and its protective mechanisms seem to go
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ischemia. Our prior work in rats demonstrated that regional
intraischemic hypothermia (RIH) during superior mesen-
teric artery occlusion (SMAO) prevented reperfusion-
induced intestinal mucosal injury and gut dysfunction, and
RIH preferentially modulated the local oxidative stress
transcriptional response during IRI.13 A subsequent clini-
cal translational study demonstrated that cold visceral per-
fusion during thoracoabdominal aortic aneurysm (TAAA)
repair improved survival in a subset of critically ill patients
(ie, those who developed postoperative acute kidney injury)
despite limited effects on the target organ.14 These findings
suggest potential systemic or distant organ therapeutic
effects of visceral cooling during TAAA repair. The aim of
this laboratory investigation is to gain a better understand-
ing regarding the effects of RIH on distant organ dysfunc-
tion during mesenteric IRI.
We investigated structural, functional, and transcrip-
tional changes in the lung during mesenteric IRI in rats and
hypothesized that regional gut hypothermia during SMAO
protects the lung and preferentially modulates the IRI-
activated transcriptome in the rat lung. To address this
hypothesis, we used an established rodent model of mesen-
teric IRI that is known to cause local and distant organ
injury and discovered lung microvascular injury and inflam-
mation during mesenteric IRI that was mitigated by RIH.
We then conducted global gene expression profiling of
lung tissues during mesenteric IRI with and without RIH.
Using a candidate gene approach, we identified ischemia-
specific changes in the lung transcriptome that are sup-
pressed by hypothermia and that include prominent genes
involved in inflammation and leukocyte chemotaxis. Select
genes associated with neutrophil activation and that dem-
onstrated major changes in expression (ie, CXCL-1 and
Lipocalin-2) were validated by qualitative real-time reverse-
transcription polymerase chain reaction (RT-PCR). To fur-
ther identify key biologic processes involved in the distant
organ protective effects of RIH, gene ontology (GO) analysis
demonstrated early suppression of genes related to inflamma-
tion, cell adhesion, and the innate immune response, and
activation of genes related to the defense response. This study
identifies potential novel diagnostic and therapeutic targets
and provides a platform for further study of the distant organ
protective effects of regional hypothermia during mesenteric
IRI.
MATERIALS AND METHODS
Animal care. All procedures were approved by the
Johns Hopkins Animal Care and Use Committee and were
consistent with the National Institutes of Health (NIH)
Guide for the Care and Use of Laboratory Animals. Male
Sprague-Dawley rats (300 grams; Harlan Labs, Houston,
Tex) were housed under pathogen-free conditions accord-
ing to NIH guidelines at least 5 days before operative
procedures. The rats were fasted 18 hours before surgery
but were given free access to water. All procedures were
performed using strict sterile techniques under generalanesthesia with inhaled isoflurane. Assessment of adequate
anesthesia was obtained by paw and tail pinching.
Surgical procedures. The study design and animal
model implemented for these experiments is shown in Fig 1.
Each animal underwent a midline laparotomy with isola-
tion of the superior mesenteric artery (SMA). For rats
assigned to experimental IRI, a nontraumatic vascular
clamp was placed on the SMA for 60 minutes with (IRI-H)
or without (IRI) regional intraischemic hypothermia.
Our method for inducing regional hypothermia has
been described in detail previously.13 Briefly, RIH was
induced by exteriorizing the small intestine and placing it in
moistened gauze between two cold compresses. A temper-
ature probe was placed between the loops of bowel to
monitor regional temperature, which was maintained at
15°-20°C during ischemia. At the end of the allotted
ischemic time period, and just before clamp release, the
cold compresses were removed and the intestine was irri-
gated with warm normal saline. The laparotomy incisions
were then closed in two layers, and the rats recovered from
anesthesia on warming blankets.
Control animals underwent the identical procedure
with (Sham-H) and without (Sham) regional hypothermia.
The small intestine was exteriorized for 60 minutes and
placed between moistened gauze without placement of the
vascular clamp on the SMA, as described above. Each
animal was placed on a heating pad, and core temperature
was maintained at 37°C during the entire procedure. The
animals were sacrificed at 6 or 24 hours, and tissue was
collected for the following studies described below.
Lung histology. Lung histologic injury was assessed by
evaluation of architecture and evidence of neutrophil influx
with hematoxylin and eosin (H&E) staining, as previously
described.15 After completion of the treatment period, the
rightmain stembronchuswas identified and cross-clamped. A
tracheostomy was performed and 0.5% low-melting agarose
was instilled into the left lung at a constant pressure of 25 cm
H2O, allowing for expansion of the lung parenchyma. The
inflated lungs were fixed in 10% formalin for 48 hours and
embedded in paraffin blocks. Paraffin-embedded sections (5
m) were obtained and stained with H&E (Fisher Scientific,
Pittsburgh, Pa). Representative samples were analyzed with
lightmicroscopy (original magnification40) for evidence of
injury and neutrophil influx.
Myeloperoxidase assay. Whole lung tissue was ho-
mogenized using cell lysis buffer (Cell Signaling), and 50
L of each sample was added to a 96-well plate and
incubated with 100-L of SureBlue TMB 1-Component
Microwell Peroxidase (KPL, Gaithersburg, Md) at room
temperature for 20 minutes. The reaction was terminated
using 100 L of 0.18 M sulfuric acid. The optical density
was at 450 nm using a Kinetic Microplate Reader (Molec-
ular Devices Corporation, Sunnyvale, Calif) spectropho-
tometer. Results are expressed as ng/mg protein.
Lung permeability. Bronchoalveolar lavage (BAL)
protein concentration was performed as a surrogate for
lung microvascular permeability. BAL fluid collection was
obtained by delivering 3 mL of warm PBS by tracheotomy,
).
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for 10 minutes. Protein concentration was measured using
BCA total protein assay (Bio-Rad, Hercules, Calif) accord-
ing to the manufacturer’s protocol, and results are ex-
pressed as g/mL.
Lung wet/dry ratio. As a surrogate for lung edema,
lung tissues were obtained and wet weights determined
before placing tissues in an oven at 60°C. After 48 hours,
dry weights were measured and used to determine lung
edema [(wet weight – dry weight)/dry weight].
Statistical analysis. For measurements of BAL pro-
tein and lung wet/dry ratios, data are expressed as means
standard error of the mean and were analyzed with one-way
analysis of variance. Individual group means were com-
pared with a Tukey multiple comparison test and P values
.05 were considered significant.
Microarray methods
Transcript profiling with Illumina oligonucleotide
array. To identify potential IRI-specific distant organ
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Bioanalyzer (Agilent Technologies, Palo Alto, Calif). RNA
samples were labeled according to the chip manufacturer’s
recommended protocols. In brief, for Illumina, 0.5 g of
total RNA from each sample was labeled by using the
Illumina TotalPrep RNA Amplification Kit (Ambion, Aus-
tin, Tex) in a two-step process of complimentary DNA
(cDNA) synthesis, followed by in vitro RNA transcription.
Single-stranded RNA (cRNA) was generated and labeled
by incorporating biotin-16-UTP (Roche Diagnostics
GmbH, Mannheim, Germany), and 0.75 g of biotin-
labeled cRNA was hybridized (16 hours) to Illumina’s
Sentrix RatRef-12 v1 Expression BeadChip (22,000
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material was analyzed with the Agilent 2100 Bioanalyzer
(Agilent Technology) that requires nanogram quantities
of RNA. All RNA samples that were used for hybridiza-
tion exhibited intact 28S and 18S ribosomal RNA on
denaturing agarose gel electrophoresis; 260/280 nm
absorbance readings for both total RNAs and biotin-
cRNAs fall in the range of 1.8 to 2.1. Only samples with
yields of in vitro transcribed RNA 750 ng were hybrid-
ized to the chips. After the chips were scanned, they were
inspected for possible image artifacts.
Identification of significant transcriptional changes.
The hybridization signals were analyzed using BeadStudio
1.5.0.34 software (Illumina Inc). The resulting digitized
matrix was processed by modified for the Illumina platform
approach described previously.16 Briefly, the significance
(BeadStudio detection0.95) of hybridization signals was
tested, and “present” and “absent” transcripts were identi-
fied. The chip background and brightness was computed
using high quartile and the entire set of “absent” hybrid-
ization signals, respectively. The expression data were strat-
ified by experimental conditions and hybridization of each
transcript was evaluated for each cluster. The transcripts
determined to be “present” produced a signal at least twice
as high as that of background in at least two of three
hybridizations in any given group of rats were considered
expressed.
The signal intensity values of these transcripts from
each chip were increased by corresponding to a given chip
background value (background adjustment) and divided by
a chip brightness coefficient (normalization). The normal-
ized data then were processed by Significance Analysis of
Microarrays (SAM 2.20) using full permutation of three
control and three IRI or IRI-H samples (720 permuta-
tions) without application of arbitrary restrictions.17,18
Genes with 1.5-fold change and false discovery rate
(q value) of 5% were considered significantly associated
with IRI.
Hierarchic clustering. Fold change values for individ-
ual IRI or IRI-H samples, or both, were derived by sub-
traction of average control expression (log2 format) from
corresponding experimental expressions (log2 format).
The 300 most variable significant genes were clustered
based on a gene expression pattern similarity (Pearson
correlation) using MeV software.
Validation of gene expression data. Quantitative
real-time RT-PCR validation of selected candidate genes
was conducted as previously described.19,20 Briefly, tran-
script levels of selected candidate genes in control and
IRI-affected lung tissues were measured (n  3 per
condition) in 96-well microtiter plates with an ABI
Prism 7700 Sequence Detector Systems (Perkin-Elmer/
Applied Biosystems). Three TaqMan endogenous con-
trol genes (Gapdh, Actb, and Pgk1) were used as internal
controls for normalization. Primers and probes were
purchased from Applied Biosystems Inc in a 20X mix-
ture. All experimental protocols were based on the man-
ufacturer’s recommendation using the TaqMan Goldreal-time RT-PCR Core Reagents Kit (Perkin-Elmer/
Applied Biosystems, P/N 402876). Experimental pa-
rameters were 48°C for 30 minutes, followed by 40
cycles of 95°C for 15 seconds and 60°C for 1 minute.
Relative gene expression was calculated using the 2Ct
method, which generates fold-change values for mRNA
transcript levels expressed in IRI-treated lung samples
relative to sham-operated samples, as described
previously.20
GO and PubMatrix analysis. MAPPFinder, a tool
that integrates gene expression data with GO data, was
used to identify the significant biologic trends among the
array data collected from each experimental group. Com-
patible files were prepared using a GenMAPP converting
tool as we described previously.21 Significant bioprocesses
were selected by choosingGO terms containing5% of the
total number of genes linked by MAPPFinder. The Z score
2 and first GO node 0 criteria were also applied as
filtering conditions. The selected gene candidates were
then searched against terms of interest related to acute lung
injury including, “neutrophil,” “endothelium,” “epithe-
lium,” and “pulmonary” terms in PubMed database using
the PubMatrix automated literature search engine.22
RESULTS
Lungmorphology during mesenteric IRI. To assess
potential structural changes in the lung after experimental
IRI with and without hypothermia, H&E-stained sections
of the lung were analyzed under light microscopy and
representative sections are shown in Fig 2. IRI-treated rats
demonstrated persistent neutrophil infiltration and focal
alveolar hemorrhage, findings that were not present after
sham, sham-H, or IRI-H. To quantify neutrophil influx, we
measured myeloperoxidase (MPO) activity in all experi-
mental groups. At 24 hours, there was a significant increase
in MPO activity in IRI compared with sham controls
(7.1 0.4 vs 5.9 0.3, P .05) during normothermia but
no difference between IRI-H and sham-H (6.5  0.4 vs
6.3  0.4, P  .05).
BAL protein during mesenteric IRI. The effect of
RIH on pulmonary function during mesenteric IRI was
evaluated by measuring changes in BAL protein concentra-
tions (g/mL) as a surrogate for microvascular permeabil-
ity (Fig 3). At 24 hours, BAL protein concentration was
increased in IRI-treated rats (665  29) compared with
sham (145  24) and IRI-H (85  58).
Lung weight/dry ratios during mesenteric IRI. To
further evaluate the effect of RIH on pulmonary microvas-
cular permeability, we measured weight/dry ratios as an
indicator of pulmonary edema (Fig 4). Wet/dry ratios were
increased in IRI compared with sham (1.17  0.01 vs
1.21  0.01; P  .05) and IRI-H (1.21  0.01 vs 1.13 
0.001, P  .05).
Gene expression changes in the lung during mesen-
teric IRI. Global gene expression profiling is a robust tool
for identification of diagnostic and mechanism-related can-
didate genes. To evaluate the lung genomic response to
mesenteric IRI with and without hypothermia, we con-
osin s
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tissue obtained at 6 or 24 hours after sham, sham-H, IRI,
and IRI-H. Total RNA was isolated from rat lungs (n 
Fig 2. Effect of regional hypothermia on lung injury du
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Fig 3. Effect of regional hypothermia (H) on lung bronchoalveolar
lavage (BAL) protein during mesenteric ischemia-reperfusion injury
(IRI). BAL protein concentration (mg/mL) at 24 hours was greater
during IRI compared with sham and IRI-H. *P  .05, n  5
rats/group. The range bars show the standard error of the mean.3/group) and hybridized to Illumina’s Sentrix ExpressionBead chip (22,000 probes). At 6 hours, SAM of expres-
sion profiles identified 437 lung genes with increased ex-
pression during IRI compared with sham, of which 205
genes were also activated in IRI-H treated groups. There-
esenteric ischemia-reperfusion injury (IRI). Represen-
ric artery occlusion, with and without hypothermia (H)
influx (arrowhead) and alveolar hemorrhage (arrow) not
tain; original magnification 40).
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Fig 4. Effect of regional hypothermia on lung edema during
mesenteric ischemia-reperfusion injury (IRI). Lung edema (wet/
dry ratio) was increased in IRI compared with sham and IRI-
hypothermia (H). *P  .05, n  5 rats/group. The range bars
show the standard error of the mean.ring m
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mia. In addition, we identified activation of 33 IRI-H
specific genes. At 24 hours, there were only eight IRI-
activated genes compared with sham, and there were no
significant lung gene changes in the IRI-H treated group
compared with sham controls.
To investigate potential differences in the lung
genomic response to IRI and IRI-H, hierarchic cluster
analysis of the most significantly affected genes identified
groups of genes with similar as well as discordant expression
patterns between the two treatment groups (Fig 5). The
detailed analysis of the most differentially expressed genes
between IRI- and IRI-H–treated animals are presented in
Table I. Of note, several prominent genes related to leuko-
cyte activation and trafficking, such as chemokine ligand 1
(CXCL-1) and lipocalin-2 (lcn-2), were suppressed by hy-
pothermia.
Validation of gene expression profiling findings.
To validate the results of our gene expression profiling
studies, quantitative real-time RT-PCR measurements of
selected genes was conducted using the TaqMan assay as
described in Methods. The overall agreement between
gene expression by microarray analysis and by the Taq-
Man assay was good, and the fold changes for the
selected genes (lcn-2 and CXCL1) are demonstrated in
Fig 6. These genes were chosen for validation based on
the most potentially relevant and representative signifi-
Fig 5. Hierarchic cluster analysis of lung gene express
shown at 6 and 24 hours. Each column represents an
Hierarchic clustering using Pearson’s correlation det
clusters demonstrated clear differences in gene expre
Genes from these clusters are highlighted with yell
up-regulation, and green indicates down-regulatio
controls.cantly increased gene expression changes after IRI.Identification of ischemia-specific biologic pro-
cesses attenuated by intraischemic hypothermia. Once
significant differences in lung genomic responses be-
tween IRI and IRI-H were established, we focused on
elucidation of potential mechanistic pathways unique to
mesenteric IRI-induced lung structural and functional
changes. Using MAPPFinder, we performed GO analysis
of the 232 IRI-specific lung candidate genes that were
suppressed by hypothermia and the 33 hypothermia-
specific genes activated at 6 hours. GO analysis identified
hypothermia-induced suppression of genes related to
inflammation, cell adhesion, and innate immune re-
sponse among others, and showed predominant activa-
tion of genes related to amine and lipid metabolism and
defense response (Table II).
To further validate the biologic relevance of the lung
candidate genes involved in these bioprocesses, a qualita-
tive analysis of the IRI and hypothermia-specific transcripts
was conducted using PubMatrix, an automated literature
search engine (http://pubmatrix.grc.nia.nih.gov). The
232 hypothermia-suppressed genes from the bioprocesses
identified in the 6-hour GO analysis were matched against
the terms “neutrophil,” “endothelium,” “epithelium,” and
“pulmonary” in the PubMed database. The most com-
monly cited genes related to these terms are presented in
Table III and are listed according to weighted distribution
between PMN or tissue based on the number of PubMed
uring mesenteric ischemia-reperfusion injury (IRI) is
imental condition of the corresponding lung sample.
ed five major clusters (blue triangles), of which two
between IRI and IRI-hypothermia (H) at 6 hours.
ctangles and are listed on the right. Red indicates
gene expression with respect to correspondingion d
exper
ermin
ssion
ow re
n ofmatches.
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Mesenteric IRI is a common clinical condition in vas-
Table I. Top differentially expressed lung genes between
(IRI-H)
Gene title Symbol
Suppressed by hypothermia
Actin alpha 1 skeletal muscle Acta1
Lipocalin 2 Lcn2
Chemokine (C-X-C motif) ligand 1 Cxcl1
Peripherin 1 Prph1
LOC500721 LOC500721
Metallothionein Mt1a
Chemokine (C-X-C motif) ligand 2 Cxcl2
LOC500720 LOC500720
Nitric oxide synthase 2 inducible Nos2
Ring finger protein 30 Rnf30
Growth arrest and DNA-damage-inducible
45 gamma Gadd45g
Ferredoxin 1 Fdx1
Hyaluronan synthase 1 Has1
Laminin alpha 5 Lama5
Transglutaminase 1 Tgm1
Interferon-induced transmembrane protein 6 Ifitm6
Recovered by hypothermia
Similar to 40S ribosomal protein S9 LOC300278 	
Similar to 40S ribosomal protein S9 LOC367102 	
Ribosomal protein S9 Rps9 	
Cytochrome P450 family 2 subfamily
e polypeptide 1 Cyp2e1 	
Guanylate cyclase 1 soluble beta 3 Gucy1b3 	
Chemokine (C-C motif) ligand 5 Ccl5 	
25
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C
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Lipocalin -2 CXCL-1  
Fig 6. Expression of lipocalin-2 and chemokine ligand 1 (CXCL-1)
genes in the lung by Ilumina microarray and quantitative real-time
reverse-transcription polymerase chain reaction (RT-PCR). The relative
fold-change (at 6 hours) identified bymicroarray analysis (filled bars) and
real-timeRT-PCR (open bars) was calculated for IRI and IRI-H samples
with respect to corresponding shams and is represented as mean 
standard error of the mean. *Significant changes in gene expression
between sham and treatment groups by either unpaired t-test (real-time
RT-PCR) or significance analysis ofmicroarrays (SAM;microarray).P
.05 or q 5%, respectively, n 3 samples/group.cular surgical patients and is associated with significantmorbidity and mortality, for which there are virtually no
therapeutic options. It promotes local synthesis and release
of downstream inflammatory mediators that exacerbate gut
injury and “prime” circulating neutrophils for enhanced
superoxide anion production and subsequent remote organ
injury.23,24 Complex thoracoabdominal aortic aneurysm
(TAAA) repair results in obligatory mesenteric ischemia
during repair of the visceral segment, and visceral organ IRI
has been associated with distant organ injury, subsequent
multiple organ failure (MOF), and death in clinical stud-
ies.25,26 In a recent prospective study of 10 patients under-
going TAAA repair, Feezor et al27 identified adverse clinical
outcome by blood leukocyte genomic and plasma pro-
teomic responses after surgery. Using gene expression pro-
filing and multiplex proteomic analysis, the authors identi-
fied time-dependent changes in gene expression that
predicted subsequent organ dysfunction. This study high-
lights the potential utility of microarray analysis in preop-
erative risk assessment and as a potential tool to determine
diagnostic and therapeutic targets of visceral IRI-induced
MOF.
Surgical adjuncts to reduce the postoperative sequelae
of visceral IRI during TAAA repair have focused on main-
taining distal aortic perfusion and selective visceral cooling
during repair of the visceral segment. Randomized compar-
isons of cold vs warm crystalloid and cold crystalloid vs cold
blood perfusion have demonstrated the therapeutic bene-
mia-reperfusion injury (IRI) and IRI with hypothermia
6 hours 24 hours
IRI-H IRI-H/IRI Ratio IRI IRI-H IRI-H/IRI ratio
	1.44 0.17 1.11 1.61 1.45
1.76 0.28 6.99 6.42 0.92
2.26 0.30 1.65 4.54 2.76
	1.40 0.31 	1.63 	1.11 1.47
	1.26 0.32 	1.42 1.11 1.57
3.11 0.33 2.05 7.05 3.44
1.69 0.36 1.19 2.54 2.13
	1.05 0.36 	1.46 1.25 1.82
1.66 0.41 1.18 1.95 1.66
1.27 0.42 1.00 3.36 3.37
1.92 0.42 1.11 1.38 1.24
1.09 0.42 1.54 2.65 1.72
1.11 0.46 1.33 1.35 1.01
1.02 0.49 	1.04 2.18 2.27
1.72 0.50 1.29 1.71 1.32
2.68 0.69 10.06 4.94 0.49
1.04 4.53 	1.43 	1.54 0.93
1.20 3.15 	1.23 	1.40 0.88
1.08 2.67 	1.24 	1.42 0.87
	1.22 2.56 1.44 	1.74 0.40
	1.05 2.39 	1.02 	1.40 0.73
	1.19 2.02 1.00 	1.54 0.65ische
IRI
4.12
6.19
7.45
2.30
2.45
9.38
4.67
2.64
4.10
3.05
4.58
2.60
2.42
2.06
3.45
3.86
4.35
2.62
2.48
3.14
2.49fits of visceral cooling for organ protection during IRI.28,29
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underwent cold or warm blood visceral perfusion during
TAAA repair, Hassoun et al14 demonstrated that although
visceral cooling did not reduce the overall incidence of
postoperative kidney injury during TAAA repair, it did
improve survival in patients who developed renal failure.14
These findings suggest that regional hypothermia offers
systemic protection during visceral IRI, although the exact
mechanisms remain unclear.
In an effort to elucidate the therapeutic potential of
regional hypothermia on distant organ inflammation and
injury during mesenteric IRI, our laboratory has developed
a rodent model of regional intraischemic hypothermia to
study local and remote organ injury during SMAO. Early
experimental studies using this model have shown that
hypothermia confers local gut structural and functional
protection by preserving mucosal integrity and improving
intestinal transit during mesenteric IRI, and that RIH
preferentially activates heme oxygenase-1 in the gut, while
decreasing the expression of nuclear factor 
-B and delete-
rious inducible nitric oxide synthase.13,30 On the basis of
these observations, our laboratory is now focused on the
potential for therapeutic hypothermia to confer protection
to distant organ sites during mesenteric IRI and to develop
a better understanding of its modulating effects on the
inflammatory response under these conditions.
Using a top-down approach, we conducted global gene
expression profiling of rat lung obtained at 6 and 24 hours
after mesenteric ischemia with and without RIH. To cor-
relate genomic changes with structural and functional de-
rangements in the lung, we assessed time-dependent
changes in BAL protein concentration, wet/dry ratios, and
lung histology in all experimental groups. Within 24 hours
of mesenteric ischemia, there was a significant increase in
BAL protein concentrations and wet/dry ratios, indicating
increased pulmonary microvascular permeability and lung
edema in IRI-treated animals as well as histologic evidence
of alveolar damage and neutrophil trafficking. The struc-
tural and functional changes observed at 24 hours are likely
Table II. Gene ontology (GO) analysis of top differentiall
(IRI) and IRI with hypothermia (H)
Gene ontology ID Gene ontology name
Suppressed by hypothermia
6928 Cell motility
6954 Inflammatory response
42127 Regulation of cell proliferation
7155 Cell adhesion
30154 Cell differentiation
6955 Immune response
9607 Response to biotic stimulus
Activated by hypothermia
9308 Amine metabolism
6629 Lipid metabolism
6952 Defense responsepreceded by changes in the proinflammatory transcriptomethat return to baseline within 24 hours. These observations
suggest that IRI-induced transcriptional changes occur be-
fore obvious functional or structural changes. Further-
more, neither transcriptional nor structural changes were
present in hypothermia-treated animals, suggesting prom-
inent distant organ protection under these conditions.
After determining the IRI-specific lung molecular
signature, we were able to identify and characterize the
hypothermia-suppressed lung transcriptome and validated
these findingswith real-timeRT-PCR.Using a bioinformatic-
driven approach, we determined the relevant biologic pro-
cesses associated with the alterations in the lung transcrip-
tome during mesenteric IRI with or without RIH. GO
analysis identified hypothermia-induced suppression of
genes related to inflammation, cell adhesion, and the innate
immune response, and showed activation of genes related
to amine and lipid metabolism and the defense response.
Interestingly, among the top hypothermia-suppressed
genes are CXCL-1, CXCL-2, and lipocalin-2, which all
code for proteins prominently associated with neutrophil
trafficking and activation. The biologic relevance of these
top suppressed genes was validated by using an automated
literature search engine, PubMatrix (http://pubmatrix.
grc.nia.nih.gov). The weighted distribution of the most
commonly cited genes were matched to the terms “neutro-
phil” and tissue-specific components such as “epithelium”
or “endothelium,” thus allowing for future mechanism-
based studies of the therapeutic potential of RIH focusing
on its specific effects on leukocyte- or tissue-specific recep-
tors.
Indeed, activation and migration of circulating neutro-
phils are central events in the development of acute lung
injury.31,32 Chemokines are important mediators of neu-
trophil recruitment and activation in the lung in response to
an inflammatory stimulus. CXCL-1 and CXCL-2 are glu-
tamic acid-leucine-arginine (ELR) chemokines that act
through a shared G-protein-coupled receptor, CXCR2.
Studies have highlighted the importance of CXCR2 ligand-
mediated lung injury and have demonstrated that increased
ressed lung genes between ischemia-reperfusion injury
Changed
genes (No.)
Measured
genes (No.)
Changed
genes (%) Z score
11 88 12.5 4.352
8 80 10.0 2.959
9 108 8.33 2.528
14 169 8.28 3.154
10 130 7.69 2.391
16 230 6.96 2.619
17 269 6.32 2.279
4 122 3.28 3.924
4 182 2.20 2.886
4 250 1.60 2.142y expCXCL-1 and CXCL-2 expression parallels neutrophil se-
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Gene
symbol
PubMed search terms
Gene title Neutrophil Endothelium Epithelium Pulmonary Ratio PMN/tissueb Distribution
Neutrophil cytosolic factor 1 Ncf1 44 0 0 2 44.00
Neutrophil cytosolic factor 2 Ncf2 17 0 0 3 17.00
Lipocalin-2 Lcn2 256 5 26 39 8.26
Chemokine ligand 2 Cxcl2 664 44 88 463 5.03 PMN
Chemokine ligand 1 Cxcl1 761 94 162 269 2.97
Biregional cell adhesion
molecule-related/down-
regulated by oncogenes
binding protein Boc 72 7 23 57 2.40
Chemokine ligand 3 Ccl3 248 55 76 249 1.89
Lipopolysaccharide binding
protein Lbp 95 28 51 96 1.20 Even
CD 14 Antigen Cd14 658 300 381 533 0.97
Tumor necrosis factor
receptor superfamily 12 Tnfrsf1a 19 8 13 17 0.90
MAP kinase-activated
protein kinase 2 Mapkapk2 25 23 27 20 0.50 Tissue
CSX-associated LIM Cal 33 18 51 168 0.48
Signal transducer and
activator of transcription 3 Stat3 158 111 253 342 0.43
Coagulation factor 3 F3 22 15 42 69 0.39
Spermidine/spermine N1-
acetyl transferase Sat 18 19 40 182 0.31
Inhibitor of kappa B kinase
beta Ikbkb 61 80 138 166 0.28
Complement component 4
gene 2 C4-2 4 3 12 7 0.27
Plasminogen activator tissue Plat 10 19 19 24 0.26
Desmin Des 630 755 1663 3266 0.26
Guanine deaminase Gda 8 9 22 95 0.26
Prostaglandin-endoperoxide
synthase 2 Ptgs2 397 605 1046 1139 0.24
Period homolog 1 Per1 2 1 8 18 0.22
NAD(P)H dehydrogenase
quinone 1 Nqo1 10 18 29 140 0.21
Ectonucleotide
pyrophosphatase/
phosphodiesterase 2 Enpp2 2 2 8 10 0.20
Runt-related transcription
factor 1 Runx1 12 34 38 10 0.17
Gap junction membrane
channel protein alpha 1 Gja1 2 5 10 8 0.13
Kirsten rat sarcoma viral
oncogene homologue
2 (active) Kras2 25 44 152 265 0.13
Vasodilator-stimulated
phosphoprotein Vasp 13 50 54 21 0.13
Secreted phosphoprotein 1 Spp1 22 43 137 79 0.12
Tissue inhibitor of
metalloproteinase 1 Timp1 5 13 28 35 0.12
Matrix Gla protein Mgp 5 17 34 36 0.10
Oxidized low-density
lipoprotein (lectin-like)
receptor 1 Oldlr1 3 16 15 1 0.10
Elongation factor RNA
polymerase II Ell 2 3 20 74 0.09
Neurturin Nrtn 1 1 12 1 0.08
P450 (cytochrome)
oxidoreductase Por 5 18 49 124 0.07
Glutathione peroxidase 2 Gpx2 1 0 14 9 0.07
Activating transcription
factor 4 Atf4 1 7 14 12 0.05Kruppel-like factor 5 Klf5 1 7 20 4 0.04
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study, we identified CXCL-1 and CXCL-2 among the top
lung candidate genes suppressed by hypothermia, and
based on these observations, note that suppression of
CXCR-2 ligand-mediated events may confer the protective
effect of RIH on distant organ dysfunction.
We also identified and validated hypothermia-induced
suppression of lipocalin-2, also known as lipocalin-associated
MMP-9 or NGAL. Lipocalins are small, secreted proteins
that form complexes with other macromolecules, including
neutrophil gelatinase, to form NGAL, which consists of
a stable complex between lipocalin and MMP-9. MMPs
are preformed granules stored in mature neutrophils that
are released in response to chemokine stimulation and are
important in extracellular matrix degradation, tissue destruc-
tion, and cellular migration.35,36 Clinical studies have im-
plicated MMPs, particularly MMP-8 and MMP-9, as me-
diators of pulmonary inflammation in acute and chronic
pulmonary disease states.37 In our study, we found early
suppression of lung lipocalin-2 in RIH-treated animals,
making it an attractive candidate for further investigation as
a potential mediator of hypothermia-induced lung protec-
tion.
A potential limitation of our study is the absence of gene
expression profiling of the postischemic intestine. Without
these data, it is difficult to conclude if regional hypothermia
modulates the lung transcriptome in a unique fashion or if the
observed gene expression changes in the lung parallel those in
the gut. We identified top hypothermia-suppressed lung
genes as those related to neutrophil trafficking and activation,
Table III. Continued
Gene
symbolGene title Neutrophil Endoth
Insulin-like growth factor 1
receptor Igf1r 7 59
Hyaluronan synthase 1 Has1 1 12
Forkhead box A2 Foxa2 1 3
Wingless-related MMTV
integration site 4 Wnt4 0 1
Solute carrier family
7 (cationic amino acid
transporter y system)
member 1 Slc7a1 0 12
Tumor-associated protein
1 (Slc7a5) Slc7a5 0 6
Procollagen type VII alpha 1 Col7a1 0 0
Laminin alpha 5 Lama5 0 2
Low-density lipoprotein
receptor-related protein 6 Lrp6 0 0
Huntingtin-associated
protein 1 (Hap1)
transcript variant 2 Hap1 0 2
Surfactant-associated
protein B Sftpb 0 0
PMN, Polymorphonuclear.
aGenes that had at least 10 hits in one category were retained.
bFor calculation of PMN/tissue ratio, zeroes were substituted with 1.which may also be dampened in the gut as well.Furthermore, our study used profound regional hypo-
thermia (15°-20°C) to achieve distant organ protection,
which may have deleterious tissue consequences later. The
effects of more moderate hypothermia on both local and
distant organ dysfunction are largely unknown and need
further investigation. Another potential confounding fac-
tor is the use of topical cooling to achieve regional hypo-
thermia. Clinical studies examining the utility of regional
hypothermia have achieved this by perfusing cold blood or
saline through the organ of interest. In our model, only
topical hypothermia was used, and we therefore did not mon-
itor the potential hemodynamic effects of using cold perfusate
to achieve regional hypothermia. The potential hemodynamic
consequences of using a cold perfusate would provide useful
information for translation into a clinical model.
CONCLUSIONS
Clinical and experimental studies have demonstrated
the promise of hypothermia as a rescue strategy after
planned and unplanned ischemic events. Therapeutic hy-
pothermia is a well-accepted postresuscitation strategy to
reduce neurologic injury, improve myocardial function,
and improve overall survival in patients with return of
spontaneous circulation after out-of-hospital cardiac arrest.
In an effort to optimize the therapeutic benefit of hypo-
thermia, preliminary studies are establishing the optimal
duration, target temperature, rate, and means of cool-
ing.38-40 Although a large body of evidence supports the
beneficial effects of systemic hypothermia, studies regard-
ing use of hypothermia as a focused strategy for in vivo
PubMed search terms
Epithelium Pulmonary Ratio PMN/tissueb Distribution
158 161 0.03
22 17 0.03
45 61 0.02
26 5 0.04
11 5 0.04
13 13 0.05
13 0 0.08
10 4 0.08
10 4 0.10
7 13 0.11
7 48 0.14eliumorgan protection have been limited. Using an established
JOURNAL OF VASCULAR SURGERY
Volume 52, Number 4 Santora et al 1013model of rodent SMAO, we have identified deleterious
lung structural and functional changes during IRI that were
mitigated by regional intraischemic hypothermia. Further-
more, RIH preferentially modulates the IRI-activated lung
transcriptome by down-regulation of select proinflamma-
tory genes and leukocyte chemoattractants. This study
identifies potential novel diagnostic and therapeutic targets
and provides a platform for further study of the distant
organ protective effects of regional hypothermia during
mesenteric IRI.
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